Search results for "ffpe challenges"
Selected Filters:
Intelligent flash purification using TLC and mass spectrometry
The evolution of immune cell killing assays using live-cell analysis
Sartorius white paper on enhanced data analytics and translational models
Revolutionize care with pioneering bispecific antibody therapy
Jiseon Kim, Senior Scientist at ProGen, explores the transformative potential of a bispecific antibody-based drug to lay the foundation for improved healthcare quality
Unlocking the potential of the multi-attribute method (MAM): The future of biopharma
New eBooks by Waters Corporation reveal the capabilities, adoption trends, and future of MAM for biotherapeutic analysis
Cellular decision making in normal and leukemic blood stem cells
This guest editorial explores how advances in single-cell technologies to reveal novel insights into hematopoietic development
Small molecule therapeutics continue to have a big impact on the pharmaceutical industry
Discover the latest technologies and methods advancing small molecule therapeutic discovery and development, from PROTAC quantification to microsampling innovations
Innovations in cell and gene therapy development and the technologies that have advanced the field
This special feature highlights interviews and resources about the latest advances in cell and gene therapy and the technologies behind them
Innovations that will revolutionize the future of PFAS analysis
Discover the most groundbreaking recent advancements in PFAS analysis and take a look forward to the developments set to shape the future of the field
How at-home blood tests power self-health management
Study shows accessible blood-biomarker insights and online coaching substantially improve health indicators
High-resolution sampling 2D-LC for pharmaceutical impurity analysis
Cancer study emphasizes the need for non-targeted PFAS analysis
Non-targeted analysis (NTA) testing can help reveal the hidden dangers of 'forever chemicals’ following findings linking PFAS exposure to thyroid cancer
CytoSections: Validated Control for IHC, ISH, ICC
OriGene TechnologiesCytoSections is a verified, reproducible, and renewable positive control source where the target protein's expression is confirmed by western blot and IHC.
NexION® 2000 ICP Mass Spectrometer
PerkinElmerNexION 2000 ICP-MS – Triple-quad power meets single-quad versatility
Simplify volatiles analysis (Part 1): Why adopt direct MS in your lab or CRO?
Join us on Tuesday, September 15, for part one of the Syft Webinar Series on selected ion flow tube mass spectrometry
Atomic force microscopy for materials
Water needs in pharma quality control
How novel technologies are driving our understanding of the complex and dynamic nature of the human cell
SSci_CT_Manuel_Leonetti_Feb22_166_V2.txt